Back to Search Start Over

Survival in France after childhood acute leukaemia and non-Hodgkin's lymphoma (1990-2000)

Authors :
Marie-Françoise Auclerc
Denis Hémon
Catherine Patte
Anne Auvrignon
Jacqueline Clavel
Christophe Bergeron
A. Goubin
Secretariat, U754
Recherches épidémiologiques et statistiques sur l'environnement et la santé.
Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Groupe FRALLE
Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
CHU Trousseau [APHP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)
LMB
Institut Gustave Roussy (IGR)
LMT
Centre Léon Bérard [Lyon]
Source :
European Journal of Cancer, European Journal of Cancer, 2006, 42 (4), pp.534-41. ⟨10.1016/j.ejca.2005.08.041⟩, European Journal of Cancer, Elsevier, 2006, 42 (4), pp.534-41. ⟨10.1016/j.ejca.2005.08.041⟩
Publication Year :
2006
Publisher :
HAL CCSD, 2006.

Abstract

International audience; This article describes the survival after childhood acute leukaemia (AL) and non-Hodgkin's lymphoma (NHL) of French population aged less than 15 years. The French National Registry of Childhood Leukaemia and Lymphoma recorded 3995 cases of acute lymphoblastic leukaemia (ALL), 812 of acute myeloid leukaemia (AML) and 1137 of NHL over the period from 1990 to 2000. Overall survival rates at 5 years were 82% (95% CI 80-83), 58% (95% CI 54-61) and 87% (95% CI 85-89) for ALL, AML and NHL, respectively. Survival after AL increased from 77% (95% CI 75-80) in 1990-1992 to 85% (95% CI 83-87) in 1997-2000 for ALL and from 47% (95% CI 41-54) to 61% (95% CI 55-67) for AML. Among AL cases, children aged 1-4 years had the most favourable prognosis. Down's syndrome was associated with poor survival after ALL. No gender-related variations in survival were in evidence. The results reported herein are similar to those reported by other European registries and clinical trials.

Details

Language :
English
ISSN :
19901992 and 09598049
Database :
OpenAIRE
Journal :
European Journal of Cancer, European Journal of Cancer, 2006, 42 (4), pp.534-41. ⟨10.1016/j.ejca.2005.08.041⟩, European Journal of Cancer, Elsevier, 2006, 42 (4), pp.534-41. ⟨10.1016/j.ejca.2005.08.041⟩
Accession number :
edsair.doi.dedup.....8b16781d11949783f9f448b7e594194d
Full Text :
https://doi.org/10.1016/j.ejca.2005.08.041⟩